A similar approach was used with the coupling of LHN/C to epidermal growth factor (LHN/C-EGF) to inhibit the release of mucin by pulmonary epithelial A549 cells in the treatment of asthma or chronic obstructive pulmonary disease [162]. Here, EGF is linked to asthma.